Using the 2−ΔΔCt method, the relative expression of TBL1XR1 at the mRNA level was significantly higher in the CAD group than it was in the control group (1.71 ± 0.96 vs. 1.00 ± 0.34; t = 4.65, p < 0.01; Figure 1). Here, TBL1XR1 is linked to coronary artery disorder.